Logo image of INCR

INTERCURE LTD (INCR) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:INCR - IL0011063760 - Common Stock

1.14 USD
-0.04 (-3.39%)
Last: 12/24/2025, 7:39:05 PM

INCR Key Statistics, Chart & Performance

Key Statistics
Market Cap62.34M
Revenue(TTM)238.84M
Net Income(TTM)-67.80M
Shares54.68M
Float40.44M
52 Week High1.79
52 Week Low1.12
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-0.46
PEN/A
Fwd PE6.16
Earnings (Next)04-29 2026-04-29
IPO2007-07-26
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals


INCR short term performance overview.The bars show the price performance of INCR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -5 -10 -15 -20

INCR long term performance overview.The bars show the price performance of INCR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of INCR is 1.14 USD. In the past month the price decreased by -12.31%. In the past year, price decreased by -29.9%.

INTERCURE LTD / INCR Daily stock chart

INCR Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 48.98 1.02T
JNJ JOHNSON & JOHNSON 20.02 500.60B
MRK MERCK & CO. INC. 12.08 264.21B
PFE PFIZER INC 7.82 142.31B
BMY BRISTOL-MYERS SQUIBB CO 8.34 111.38B
ZTS ZOETIS INC 19.79 55.30B
RPRX ROYALTY PHARMA PLC- CL A 9.55 22.66B
VTRS VIATRIS INC 5.25 14.10B
ELAN ELANCO ANIMAL HEALTH INC 23.31 11.12B
CORT CORCEPT THERAPEUTICS INC 94.99 8.79B
AXSM AXSOME THERAPEUTICS INC N/A 7.74B
BLTE BELITE BIO INC - ADR N/A 5.41B

About INCR

Company Profile

INCR logo image InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Company Info

INTERCURE LTD

Medinat HaYehudim 85

Herzliya 27604 IL

CEO: Alistair Macdonald

Employees: 320

INCR Company Website

INCR Investor Relations

Phone: 972774605012

INTERCURE LTD / INCR FAQ

What does INTERCURE LTD do?

InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.


What is the current price of INCR stock?

The current stock price of INCR is 1.14 USD. The price decreased by -3.39% in the last trading session.


What is the dividend status of INTERCURE LTD?

INCR does not pay a dividend.


How is the ChartMill rating for INTERCURE LTD?

INCR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What is the employee count for INCR stock?

INTERCURE LTD (INCR) currently has 320 employees.


What is the market capitalization of INCR stock?

INTERCURE LTD (INCR) has a market capitalization of 62.34M USD. This makes INCR a Micro Cap stock.


INCR Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

INCR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to INCR. INCR may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INCR Financial Highlights

Over the last trailing twelve months INCR reported a non-GAAP Earnings per Share(EPS) of -0.46. The EPS decreased by -8.71% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -8.62%
ROE -14.9%
Debt/Equity 0.23
Chartmill High Growth Momentum
EPS Q2Q%-822.04%
Sales Q2Q%236.68%
EPS 1Y (TTM)-8.71%
Revenue 1Y (TTM)-32.82%

INCR Forecast & Estimates

For the next year, analysts expect an EPS growth of 1550% and a revenue growth 39.3% for INCR


Analysts
Analysts82.86
Price TargetN/A
EPS Next Y1550%
Revenue Next Year39.3%

INCR Ownership

Ownership
Inst Owners3.91%
Ins Owners26.05%
Short Float %0.04%
Short Ratio0.54